The brand name for solifenacin succinate is Vesicare [1].
What is Vesicare used for?
Vesicare is a medication prescribed to treat overactive bladder (OAB) with symptoms such as urinary urgency, frequency, and incontinence [2]. It works by relaxing the bladder muscles, which helps to reduce these symptoms [3].
How does Vesicare work?
Solifenacin succinate, the active ingredient in Vesicare, is a muscarinic receptor antagonist [4]. It specifically targets M3 muscarinic receptors in the bladder muscle. By blocking the action of acetylcholine at these receptors, it prevents involuntary bladder muscle contractions, leading to increased bladder capacity and reduced urgency and frequency of urination [3][4].
When does Vesicare's patent protection end?
The patent exclusivity for Vesicare has largely expired in major markets, paving the way for generic versions. For instance, in the United States, the primary patents protecting Vesicare expired around 2015 [5]. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals, providing detailed timelines for drugs like Vesicare [5].
Can I get a generic version of Vesicare?
Yes, generic versions of solifenacin succinate are available. Following the expiration of brand-name patents, pharmaceutical companies can manufacture and market generic alternatives, which are typically less expensive than the branded drug [5].
What are the common side effects of Vesicare?
Common side effects associated with Vesicare can include dry mouth, constipation, blurred vision, and difficulty emptying the bladder [2]. Patients experiencing severe or persistent side effects should consult their healthcare provider.
How does Vesicare compare to other overactive bladder medications?
Vesicare belongs to a class of drugs known as anticholinergics or antimuscarinics, which are common treatments for OAB. Other medications in this class include oxybutynin, tolterodine, and darifenacin. While they share a similar mechanism of action, differences in their receptor selectivity and pharmacokinetics can lead to variations in efficacy and side effect profiles among these drugs [4].
What are the risks associated with taking Vesicare?
Beyond common side effects, Vesicare carries risks, particularly for individuals with certain pre-existing conditions. It can worsen conditions like glaucoma, myasthenia gravis, and severe ulcerative colitis or toxic megacolon [2]. Patients with reduced bladder emptying or gastrointestinal obstruction should also exercise caution.
What is the typical cost of Vesicare and its generics?
The cost of Vesicare can vary significantly depending on insurance coverage, pharmacy, and location. Generic versions of solifenacin succinate are generally more affordable than the brand-name drug [5].
Who manufactures Vesicare?
Vesicare was originally developed and marketed by Astellas Pharma [1].
Sources:
[1] https://www.vesicare.com/
[2] https://www.nhs.uk/medicine-finder/medicines/solifenacin-succinate/
[3] https://www.drugs.com/vesicare.html
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732033/
[5] https://drugpatentwatch.com/